{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:49:28Z","timestamp":1793396968684,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.canlet.2024.217415","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:33:47Z","timestamp":1735328027000},"page":"217415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["RNF5 exacerbates steatotic HCC by enhancing fatty acid oxidation via the improvement of CPT1A stability"],"prefix":"10.1016","volume":"611","author":[{"given":"Xi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Wen-Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kequan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiangen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-3803","authenticated-orcid":false,"given":"Yufeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2024.217415_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.canlet.2024.217415_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.canlet.2024.217415_bib3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.canlet.2024.217415_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217415_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217415_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jhep.2021.09.007","article-title":"NAFLD-driven HCC: safety and efficacy of current and emerging treatment options","volume":"76","author":"Foerster","year":"2022","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217415_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.canlet.2024.217415_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gutjnl-2017-315448","article-title":"beta-catenin-activated hepatocellular carcinomas are addicted to fatty acids","volume":"68","author":"Senni","year":"2019","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.canlet.2024.217415_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1477-2574.2010.00207.x","article-title":"Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma","volume":"12","author":"Wu","year":"2010","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.canlet.2024.217415_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/HEP.0000000000000553","article-title":"Multiomics identifies metabolic subtypes based on fatty acid degradation allocating personalized treatment in hepatocellular carcinoma","volume":"79","author":"Li","year":"2024","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.canlet.2024.217415_bib11","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1002\/hep.32061","article-title":"The E3 ubiquitin ligase ring finger protein 5 ameliorates NASH through ubiquitin-mediated degradation of 3-hydroxy-3-methylglutaryl CoA reductase degradation protein 1","volume":"74","author":"Yang","year":"2021","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.canlet.2024.217415_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nprot.2012.024","article-title":"A positive\/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue","volume":"7","author":"Yuan","year":"2012","journal-title":"Nat. Protoc."},{"issue":"7885","key":"10.1016\/j.canlet.2024.217415_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41586-021-04075-0","article-title":"Dietary palmitic acid promotes a prometastatic memory via Schwann cells","volume":"599","author":"Pascual","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.canlet.2024.217415_bib14","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.canlet.2024.217415_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7150\/ijbs.76798","article-title":"Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner","volume":"19","author":"Shi","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2024.217415_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.immuni.2009.01.008","article-title":"The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA","volume":"30","author":"Zhong","year":"2009","journal-title":"Immunity"},{"issue":"18","key":"10.1016\/j.canlet.2024.217415_bib17","doi-asserted-by":"crossref","first-page":"12099","DOI":"10.1074\/jbc.M808222200","article-title":"Regulation of endoplasmic reticulum-associated degradation by RNF5-dependent ubiquitination of JNK-associated membrane protein (JAMP)","volume":"284","author":"Tcherpakov","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.canlet.2024.217415_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41420-022-01204-0","article-title":"Role of K63-linked ubiquitination in cancer","volume":"8","author":"Cao","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.canlet.2024.217415_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70715","article-title":"Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation","volume":"10","author":"Lin","year":"2021","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.canlet.2024.217415_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108021","article-title":"Acetylation stabilizes phosphoglycerate dehydrogenase by disrupting the interaction of E3 ligase RNF5 to promote breast tumorigenesis","volume":"32","author":"Wang","year":"2020","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.canlet.2024.217415_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071802","article-title":"Targeting of ubiquitin E3 ligase RNF5 as a novel therapeutic strategy in neuroectodermal tumors","volume":"14","author":"Principi","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.canlet.2024.217415_bib22","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41419-024-06782-8","article-title":"Human gastric cancer progression and stabilization of ATG2B through RNF5 binding facilitated by autophagy-associated CircDHX8","volume":"15","author":"Wei","year":"2024","journal-title":"Cell Death Dis."},{"issue":"22","key":"10.1016\/j.canlet.2024.217415_bib23","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108065","article-title":"PKM2-TMEM33 axis regulates lipid homeostasis in cancer cells by controlling SCAP stability","volume":"40","author":"Liu","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2024.217415_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-biochem-032620-104421","article-title":"Driving E3 ligase substrate specificity for targeted protein degradation: lessons from nature and the laboratory","volume":"91","author":"Cowan","year":"2022","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.canlet.2024.217415_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/nar\/gky1012","article-title":"IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner","volume":"47","author":"Muller","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2024.217415_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216510","article-title":"TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer","volume":"581","author":"Jiang","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2024.217415_bib27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.canlet.2024.217415_bib28","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1158\/0008-5472.CAN-05-4673","article-title":"Fatty acid synthase and cancer: new application of an old pathway","volume":"66","author":"Kuhajda","year":"2006","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.canlet.2024.217415_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2024.217415_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.canlet.2018.08.006","article-title":"Fatty acid oxidation: an emerging facet of metabolic transformation in cancer","volume":"435","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.canlet.2024.217415_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2024.217415_bib32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000491779","article-title":"Development of a genetic and clinical data-based (GC) risk score for predicting survival of hepatocellular carcinoma patients after tumor resection","volume":"48","author":"Chen","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"15","key":"10.1016\/j.canlet.2024.217415_bib33","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.7150\/ijbs.64714","article-title":"Targeted Inhibition of LPL\/FABP4\/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer","volume":"17","author":"Yang","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.canlet.2024.217415_bib34","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/hep.32359","article-title":"Therapeutic efficacy of FASN inhibition in preclinical models of HCC","volume":"76","author":"Wang","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.canlet.2024.217415_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.canlet.2024.217415_bib36","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","article-title":"CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity","volume":"67","author":"Naoto","year":"2018","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.canlet.2024.217415_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez Javier","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2024.217415_bib38","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524008103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524008103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T22:58:54Z","timestamp":1760741934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524008103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":38,"alternative-id":["S0304383524008103"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217415","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNF5 exacerbates steatotic HCC by enhancing fatty acid oxidation via the improvement of CPT1A stability","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217415"}}